About Index Trending news
Analyze
Top 50 Pricing
RedHill Biopharma

RedHill Biopharma

Work at RedHill Biopharma? Add yourself to this profile

RedHill Biopharma

RedHill Biopharma (NASDAQ/TASE: RDHL) is a biopharmaceutical company focused on development of late-stage drugs for inflammatory and gastrointestinal diseases

Elsewhere

Alexa global traffic share

Twitter followers

Latest funding
Post-IPO equity
$11,700,000
Post-IPO equity
$8,500,000
Employees

Team size

10+

No recent coverage

Index constantly checks hot and trending companies for their latest activity. We haven't gotten to this company yet, but if you follow it you'll be the the first to know when RedHill Biopharma makes some noise.